Schlagwort: breast cancer
Changes in lung tissue indicate preparation for supporting the growth of disseminated breast cancer cells
Statins may improve survival for triple-negative breast cancer patients
Seeking a unique treatment for lobular breast cancer
Maternal diets rich in Omega-3 fatty acids may protect offspring from breast cancer, study suggests
Cholesterol metabolite induces production of cancer-promoting vesicles
New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer
The micro-environment of breast cancer in three dimensions
Review summarizes known links between endocrine disruptors and breast cancer risk
A leap forward in research on CAR T cell therapy
Exposure to common chemical during pregnancy may reduce protection against breast cancer
Breast cancer: The risks of brominated flame retardants
Making the role of AI in medicine explainable
What to do when a mammogram shows swollen lymph nodes in women just vaccinated for COVID
Drug is promising against pancreatic and breast cancers
Halt cell recycling to treat cancer
Popular breast cancer drugs don’t work the way we thought they did
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
New discovery in breast cancer treatment
Statins may protect the heart from chemotherapy treatment of early breast cancer
A global assessment of cancer genomic alterations in epigenetic mechanisms
Muhammad A Shah, Emily L Denton, Cheryl H Arrowsmith, Mathieu Lupien and Matthieu Schapira
Abstract
Background
The notion that epigenetic mechanisms may be central to cancer initiation and progression is supported by recent next-generation sequencing efforts revealing that genes involved in chromatin-mediated signaling are recurrently mutated in cancer patients.
Results
Here, we analyze mutational and transcriptional profiles from TCGA and the ICGC across a collection 441 chromatin factors and histones. Chromatin factors essential for rapid replication are frequently overexpressed, and those that maintain genome stability frequently mutated. We identify novel mutation hotspots such as K36M in histone H3.1, and uncover a general trend in which transcriptional profiles and somatic mutations in tumor samples favor increased transcriptionally repressive histone methylation, and defective chromatin remodeling.
Conclusions
This unbiased approach confirms previously published data, uncovers novel cancer-associated aberrations targeting epigenetic mechanisms, and justifies continued monitoring of chromatin-related alterations as a class, as more cancer types and distinct cancer stages are represented in cancer genomics data repositories.
Continue reading „A global assessment of cancer genomic alterations in epigenetic mechanisms“ →